Results 151 to 160 of about 5,749,461 (312)

Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia [PDF]

open access: yes, 2016
BACKGROUND:  The burden of Kaposi sarcoma (KS) in human immunodeficiency virus (HIV)-infected children and adolescents on combination antiretroviral therapy (cART) has not been compared globally.
Pediatric AIDS-Defining Cancer Project Working Group for IeDEA S, .
core  

Improving CO2 Photoconversion by Layered Materials: Boosted Optoelectronic Performance and Catalytic Activity of g‐C3N4 by Ultrasound Exfoliation

open access: yesChemCatChem, Volume 18, Issue 1, 15 January 2026.
Exfoliation by ultrasound of graphitic carbon nitride improved activity for the photoreduction of CO2. Abstract Exfoliation of graphitic carbon nitride g‐C3N4 by means of ultrasound (US) treatment at varying input power is investigated. Exfoliation of g‐C3N4 displays a strong dependence of US input power, with a slightly enhanced bandgap (2.8 eV), but ...
Matteo Tommasi   +5 more
wiley   +1 more source

Host Gene Induction and Transcriptional Reprogramming in Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8)-Infected Endothelial, Fibroblast, and B Cells [PDF]

open access: bronze, 2004
Pramod P. Naranatt   +5 more
openalex   +1 more source

Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man [PDF]

open access: yes, 2018
Our case illustrates the difficulties involved in diagnosing multicentric Castleman's disease (MCD) in a human immunodeficiency virus-infected man with febrile episodes and malaise. In the absence of well-established treatment protocols, we have chosen a
Achermann, Y.   +4 more
core  

Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen

open access: yesChemMedChem, Volume 21, Issue 1, January 2026.
It is attempted to employ proteolysis‐targeting chimeras‐based targeted protein degradation to the viral protein “Latency‐associated Nuclear Antigen” from Kaposi's sarcoma‐associated herpesvirus. While ternary complex formation is detected via native mass spectrometry, protein degradation is not observed, presumably due to insufficient permeability ...
Aylin Berwanger   +10 more
wiley   +1 more source

A Sustainable Power Production System Based on Integrated Supercritical Water Gasification of Brewer's Spent Grains and Carbon Dioxide Capture

open access: yesEnergy Technology, Volume 14, Issue 1, January 2026.
A supercritical water gasification process with syngas heat recovery is integrated into a combined cycle power system and coupled with a carbon dioxide capture unit to simultaneously produce electricity and CO2—two valuable resources for the brewing industry.
Augusto Barbosa, Eliseu Monteiro
wiley   +1 more source

Stability of HHV-8 and HIV-1 co-infection model with latent reservoirs and multiple distributed delays

open access: yesAIMS Mathematics
Human immunodeficiency virus type 1 (HIV-1) gradually destroys the CD4$ ^{+} $ T cells leading to immune system dysfunction. HIV-1 can result in acquired immunodeficiency syndrome (AIDS) if antiretroviral drugs are not used.
A. M. Elaiw   +2 more
doaj   +1 more source

Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort Study

open access: yesHematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT Primary effusion lymphoma (PEL) is a rare and aggressive B‐cell non‐Hodgkin lymphoma (NHL) that predominantly affects patients with human immunodeficiency virus infection and is strongly associated with human herpes virus 8 (HHV‐8) infection. Due to its rarity, the current understanding of PEL's epidemiology and management is largely derived ...
John L. Vaughn   +4 more
wiley   +1 more source

Human Herpesvirus 8 (HHV-8) Staining: A Savior in Early Kaposi Sarcoma. [PDF]

open access: yesCureus, 2023
Siddiqui F   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy